Listar1. Investigación por tema "Diastolic dysfunction"
Mostrando ítems 1-4 de 4
-
Diastolic dysfunction following anthracycline-based chemotherapy in breast cancer patients: incidence and predictors
(AlphaMed Press, 2015-07-16)[Abstract] INTRODUCTION: Cardiotoxicity represents a major limitation for the use of anthracyclines or trastuzumab in breast cancer patients. Data from longitudinal studies of diastolic dysfunction (DD) in this group ... -
Early and late onset cardiotoxicity following anthracycline-based chemotherapy in breast cancer patients: Incidence and predictors
(Elsevier, 2023-04-18)[Abstract] Introduction. Cardiotoxicity represents a major limitation for the use of anthracyclines or trastuzumab in breast cancer patients. Data on longitudinal studies about early and late onset cardiotoxicity in this ... -
Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term Registry
(Wiley Online Library, 2020-07-02)[Abstract] Aims. In hospitalized patients with a clinical diagnosis of acute heart failure (HF) with preserved ejection fraction (HFpEF), the aims of this study were (i) to assess the proportion meeting the 2016 European ... -
Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease
(Springer, 2016)[Abstract] There are multiple intrinsic mechanisms for diastolic dysfunction ranging from molecular to structural derangements in ventricular myocardium. The molecular mechanisms regulating the progression from normal ...